Literature DB >> 10861446

Down-regulation of drs mRNA in human colon adenocarcinomas.

M Shimakage1, K Kawahara, N Kikkawa, T Sasagawa, M Yutsudo, H Inoue.   

Abstract

We have previously reported that the drs gene, whose mRNA expression is down-regulated by retroviral oncogenes such as v-src and v-K-ras, has the ability to suppress transformation by v-src and v-K-ras in the rat cell line F2408. We have also isolated a human homolog of this gene (h-drs) and shown that expression of h-drs mRNA is markedly reduced in a variety of human cancer cell lines, including those of carcinomas of the colon, bladder, and ovary, suggesting that down-regulation of drs mRNA is correlated with the development of human cancers. To clarify the correlation between down-regulation of the drs gene and malignant tumor formation in human cancer tissues, we examined expression of drs mRNA in human normal tissues, colon adenoma, and adenocarcinoma tissues by in situ hybridization. Expression of drs mRNA was detected in most normal tissues tested, including those of the colon, bladder, and ovary. However, drs mRNA was hardly expressed in any of the colon adenocarcinoma tissues examined. Northern blot analyses confirmed these results. Neither gross deletion nor re-arrangement of the drs genome was detected by Southern blot hybridization in these adenocarcinoma tissues. drs mRNA was significantly expressed in colon adenoma with mild atypia but down-regulated in adenomas with moderate atypia and focal carcinoma. Our results indicate that down-regulation of drs mRNA is closely correlated with development of colon adenocarcinoma, suggesting a tumor-suppressor function of the drs gene in human cancers. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861446     DOI: 10.1002/1097-0215(20000701)87:1<5::aid-ijc2>3.0.co;2-y

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  A widespread peroxiredoxin-like domain present in tumor suppression- and progression-implicated proteins.

Authors:  Krzysztof Pawłowski; Anna Muszewska; Anna Lenart; Teresa Szczepińska; Adam Godzik; Marcin Grynberg
Journal:  BMC Genomics       Date:  2010-10-21       Impact factor: 3.969

2.  Down-regulation of drs mRNA in colorectal neoplasms.

Authors:  Ken-ichi Mukaisho; Masashi Suo; Misuzu Shimakage; Ryoji Kushima; Hirokazu Inoue; Takanori Hattori
Journal:  Jpn J Cancer Res       Date:  2002-08

3.  Genetic Programs Driving Oncogenic Transformation: Lessons from in Vitro Models.

Authors:  Eros Di Giorgio; Harikrishnareddy Paluvai; Raffaella Picco; Claudio Brancolini
Journal:  Int J Mol Sci       Date:  2019-12-12       Impact factor: 5.923

Review 4.  Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy.

Authors:  Yasuteru Inoue; Yukio Ando; Yohei Misumi; Mitsuharu Ueda
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.